3Daughters is revolutionizing the realm of women’s health with their groundbreaking approach to long-acting contraception. For years, women have endured excruciating pain during IUD insertion, a process that has remained largely unchanged for over three decades. Despite the demand for non-hormonal birth control options, the discomfort associated with traditional T-shaped plastic-framed IUDs has persisted, leading many women to suffer through the procedure without adequate pain management.
Enter 3Daughters, a company founded by Mary Beth Cicero, a visionary with a passion for improving women’s health outcomes. Drawing inspiration from a magnetic IUD designed for horses, Cicero set out to create a frameless, non-hormonal IUD that would eliminate insertion pain and modernize long-acting contraception. The innovative design features a self-assembling magnetic system that conforms to the uterus, replacing the rigid arms and dangling strings of traditional IUDs. This bendable, 2-millimeter inserter aims to reduce trauma during placement, offering a more comfortable experience for women.
In addition to prioritizing comfort, 3Daughters’ new system utilizes copper as the active ingredient, a material with a long history of safety and efficacy recognized by the FDA. By pursuing a 505(b)(2) FDA approval pathway, the company aims to expedite the regulatory process and bring their innovative product to market more quickly.
Despite facing challenges in early fundraising efforts, Cicero’s determination and resilience have propelled 3Daughters forward. With $6.5 million in funding secured, a working prototype developed, and discussions with the FDA underway, the company is on track to revolutionize the contraceptive landscape. A recent NIH grant and plans for Phase 1 trials signal a promising future for 3Daughters and the women they aim to serve.
As the company prepares to launch clinical trials and expand distribution, investors and industry experts are taking notice of their transformative potential. 3Daughters represents a turning point in contraceptive innovation, challenging outdated norms and offering women a new standard of care that prioritizes comfort, safety, and dignity.
With a focus on patient-centered innovation, 3Daughters is paving the way for a new era in women’s health. By reimagining the IUD experience and empowering women to make informed choices about their bodies, the company is poised to make a significant impact on the contraceptive landscape. For women who have long endured the pain of IUD insertion, 3Daughters offers hope for a future where comfort, safety, and empowerment are the norm in contraceptive care.
